Clinical Trials of Influenza Vaccines: Special Challenges

Research output: Chapter in Book/Report/Conference proceedingChapter in a book

1 Downloads (Pure)

Abstract

Clinical trials of vaccines differ from those of drugs both practically and ethically. Influenza vaccine trials pose additional challenges which flow from the seasonality of the disease and vaccine programmes and the changeability of circulating strains and epidemic size. Serological correlates are widely used in evaluating influenza vaccines but interpreting such responses is also difficult. Development and testing of vaccines for deployment in an influenza pandemic combines all these obstacles with extreme unpredictability, enormous urgency and the need for very large numbers of doses. Advances in manufacturing technology, diagnostics, identification of stable protective antigens and epitopes, new adjuvants and improved understanding of indirect and downstream effects may help to alleviate these difficulties in the future.
Original languageEnglish
Title of host publicationInfluenza Virus
Subtitle of host publicationMethods and Protocols
PublisherHumana Press
Chapter27
Pages567-573
Number of pages7
ISBN (Electronic)9781493986781
ISBN (Print)9781493986774
DOIs
Publication statusPublished - 28 Aug 2018

Publication series

NameMethods in Molecular Biology
PublisherSpringer
Volume1836
ISSN (Print)1064-3745

Keywords

  • Children
  • Influenza
  • Trials
  • Vaccines

Fingerprint Dive into the research topics of 'Clinical Trials of Influenza Vaccines: Special Challenges'. Together they form a unique fingerprint.

Cite this